03.03.26 -- CDMO Market Update: Growth, Innovation & Advanced Manufacturing

A CDMO specializing in analytical and formulation development services and cGMP manufacturing for small molecule drugs has announced the expansion of its capabilities to meet industry demand for the company’s services and expertise.

Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies for customized profiles including immediate, delayed, extended, and pulsatile delivery.

By combining deep scientific expertise with cutting-edge technology, we ensure the safety and effectiveness of each formulation through precise control of API release.

In this interview, Dr. Michael Grass discusses how the company is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.

Our mission is to provide contract manufacturing services that simplify the logistics of your drug development programs, saving you time and money, and accelerating speed to market.

Choose an experienced CDMO specializing in high-potency softgels and liquids to ensure high-quality products, responsive service, and reliable solutions across complex therapeutic areas.

Digital services that are unique in the industry, including support with augmented reality, remote diagnosis, and visual parts search. The core is the customer portal, which also integrates the machine, providing a perfect overview of all ordered and installed devices.

Learn how our chemical manufacturing facilities are equipped to support a wide range of projects with on-site pilot plants and large-scale commercial capabilities for manufacturing high-quality APIs.

Get an overview of our AI-assisted early phase toolkit, which combines predictive modeling, formulation screening, and data-driven insights to accelerate molecule progression.

Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.